PAVmed Inc reports results for the quarter ended in December - Earnings Summary

PAVmed

25/03/2024 22:39

* PAVmed Inc  PAVM.OQ  reported a quarterly adjusted loss of
$1.81​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-3.45.  The mean expectation of four analysts for the quarter
was for a loss of $1.89 per share. Wall Street expected
results to range from $-2.10 to $-1.47 per share.
    * Revenue rose 836.6% to $1.05 million from a year ago;
analysts
expected $1.05 million. 
    * PAVmed Inc's reported EPS for the quarter was a loss of
$1.81​.
    * The company reported a quarterly loss of $14.11 million.
    * PAVmed Inc shares had fallen by 38.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for PAVmed Inc is
$15.00 
This summary was machine generated from LSEG data March 25 at
10:39 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.89          -1.81          Beat
 Sep. 30 2023      -2.05          -2.40          Missed
 Jun. 30 2023      -2.85          -2.10          Beat
 Mar. 31 2023      -3.10          -2.85          Beat